220 likes | 365 Views
The Sixth Annual IGPA Conference. Country Review and Market Trends INDIA. Cascais – Portugal July 1, 2003. VISION: May 03. INDIA Country Review and Market Trends. Outline of Presentation. Introduction Domestic Market Corporate Performance Export Market R & D
E N D
The Sixth Annual IGPA Conference Country Review and Market Trends INDIA Cascais – Portugal July 1, 2003 VISION: May 03
INDIA Country Review and Market Trends Outline of Presentation • Introduction • Domestic Market • Corporate Performance • Export Market • R & D • Business Environment VISION: May 03
INDIA Country Review and Market Trends India in Perspective: 1997 Population Area Source: TIME Almanac 1999 * Includes Russia VISION: May 03
INDIA Country Review and Market Trends Domestic Market Growth 8.10% 10.40% 5.30% Source: IMS Health VISION: May 03
INDIA Country Review and Market Trends Market Share of MNCs & Local Companies Source: IMS Health VISION: May 03
INDIA Country Review and Market Trends Top 15 Therapeutic Segments Source: IMS Health VISION: May 03
INDIA Country Review and Market Trends Top 15 Therapeutic Segments Source: IMS Health VISION: May 03
INDIA Country Review and Market Trends Top Ten Brands: MAT 03/03 Source: IMS Health VISION: May 03
INDIA Country Review and Market Trends Top Ten Corporations: MAT 03/03 Source: IMS Health VISION: May 03
INDIA Country Review and Market Trends Top Ten Fastest Growing Corporations: MAT 03/03 10.00% 6.71% 13.59% 14.18% 20.67% 11.57% 11.81% 17.86% 16.94% 11.47% Source: IMS Health VISION: May 03 VISION: May ‘03
INDIA Country Review and Market Trends Region-Wise Exports: 2001-02 Source: Chemexcil VISION: May 03
INDIA Country Review and Market Trends India’s Top 20 Markets Source: Chemexcil VISION: May 03
INDIA Country Review and Market Trends DMF Approvals: 1985-2002 254 226 65 37 19 0 * Upto June 2002 Only Source: US FDA VISION: May 03
INDIA Country Review and Market Trends Summary of DMF Approvals by Company Source: US FDA VISION: May 03
INDIA Country Review and Market Trends Product Launches/ANDA Filing (IPA) Source: IPA VISION: May 03
INDIA Country Review and Market Trends R & D Expenditure (IPA) 29% 36% 34% Source: IPA VISION: May 03
INDIA Country Review and Market Trends R & D Personnel (IPA) 15% 18% 14% Source: IPA VISION: May 03
INDIA Country Review and Market Trends Regulatory Filing (IPA) Source: IPA VISION: May 03
INDIA Country Review and Market Trends No of Patents (IPA) Source: IPA VISION: May 03
INDIA Country Review and Market Trends Status of IPRs • TRIPS Compliant IPR Regime • Avails Benefits of Flexibilities • Bolar Exception • Compulsory Licensing • EMRs Effective from 2000 • To Define “Patentability” Before 1st Jan 2005 VISION: May 03
INDIA Country Review and Market Trends Regulatory Infrastructure • Evolving on the Model of the US-FDA • Import Registration Procedures in Place • New Guidelines for Clinical Trials under Implementation • WHO-GMP Standards Obligatory for All Units VISION: May 03
INDIA Country Review and Market Trends Price Control Gradual Reduction in Span of Control *Proposed VISION: May 03